TY - JOUR
T1 - Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk
AU - Baum, L.
AU - Ng, H.K.
AU - Woo, K.S.
AU - Tomlinson, B.
AU - Rainer, T.H.
AU - Chen, Xiangyan
AU - Cheung, W.S.
AU - Yin Chan, D.K.
AU - Thomas, G.N.
AU - Wai Tong, C.S.
AU - Wong, K.S.
PY - 2006/1/1
Y1 - 2006/1/1
N2 - Objectives: Paraoxonase (PON1), an enzyme associated with high-density lipoprotein (HDL) particles, inhibits oxidation and atherogenesis. We sought to investigate the association of the PON1 Q192R polymorphism with stroke and heart disease. Design and methods: In a case control study, we genotyped 242 ischemic stroke, 231 myocardial infarction (MI), and 310 healthy control subjects, all Chinese. Results: R-containing genotypes (R+) were associated with vascular disease, OR = 1.5, P = 0.03. RR was increased in MI patients who were either smokers (OR = 3.1, P = 0.01), male, or younger than 60. R+ but not RR genotypes were increased in stroke patients, particularly large artery type (OR = 2.6 and P = 0.02 for R+, OR =1.0 for RR) or among smokers. The relative dearth of RR in stroke might be due to earlier MI or death in at-risk people, such as smokers. R+ genotypes were increased with stroke in hypertensive (OR = 2.1, P = 0.02) but not normotensive (OR = 1.0) subjects. Conclusions: PON1 192R+ genotypes were associated with stroke and MI, particularly in subsets of patients, in patterns suggesting a possible survivor effect. © 2006 The Canadian Society of Clinical Chemists. All rights reserved.
AB - Objectives: Paraoxonase (PON1), an enzyme associated with high-density lipoprotein (HDL) particles, inhibits oxidation and atherogenesis. We sought to investigate the association of the PON1 Q192R polymorphism with stroke and heart disease. Design and methods: In a case control study, we genotyped 242 ischemic stroke, 231 myocardial infarction (MI), and 310 healthy control subjects, all Chinese. Results: R-containing genotypes (R+) were associated with vascular disease, OR = 1.5, P = 0.03. RR was increased in MI patients who were either smokers (OR = 3.1, P = 0.01), male, or younger than 60. R+ but not RR genotypes were increased in stroke patients, particularly large artery type (OR = 2.6 and P = 0.02 for R+, OR =1.0 for RR) or among smokers. The relative dearth of RR in stroke might be due to earlier MI or death in at-risk people, such as smokers. R+ genotypes were increased with stroke in hypertensive (OR = 2.1, P = 0.02) but not normotensive (OR = 1.0) subjects. Conclusions: PON1 192R+ genotypes were associated with stroke and MI, particularly in subsets of patients, in patterns suggesting a possible survivor effect. © 2006 The Canadian Society of Clinical Chemists. All rights reserved.
KW - Ischemic stroke
KW - Myocardial infarction
KW - Paraoxonase
KW - Polymorphism
UR - https://www.scopus.com/pages/publications/33644936372
U2 - 10.1016/j.clinbiochem.2006.01.010
DO - 10.1016/j.clinbiochem.2006.01.010
M3 - Journal article
C2 - 16472799
SN - 0009-9120
VL - 39
SP - 191
EP - 195
JO - Clinical Biochemistry
JF - Clinical Biochemistry
IS - 3
ER -